INTERNATIONAL PATENT: ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR), UNIVERSITY HEALTH NETWORK FILES APPLICATION FOR "PYRIMIDOPYRIDONE AND PTERIDONE DERIVATIVES AS INHIBITORS OF THE GCN2 KINASE, COMPOSITIONS AND USES THEREOF"

GENEVA, March 8 -- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (661 University AvenueSuite 510Toronto, Ontario M5G 0A3), UNIVERSITY HEALTH NETWORK (190 Elizabeth StreetR. Fraser Elliott Building - Room 1S-417Toronto, Ontario M5G 2C4) filed a patent application (PCT/CA2024/051124) for "PYRIMIDOPYRIDONE AND PTERIDONE DERIVATIVES AS INHIBITORS OF THE GCN2 KINASE, COMPOSITIONS AND USES THEREOF" on Aug 29, 2024. With publication no. WO/2025/043349, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AL-AWAR, Rima (1166 Bay Street...